156 related articles for article (PubMed ID: 26220048)
1. Comorbid renal tubular damage and hypoalbuminemia exacerbate cardiac prognosis in patients with chronic heart failure.
Otaki Y; Watanabe T; Takahashi H; Funayama A; Kinoshita D; Yokoyama M; Takahashi T; Nishiyama S; Arimoto T; Shishido T; Miyamoto T; Konta T; Kubota I
Clin Res Cardiol; 2016 Feb; 105(2):162-71. PubMed ID: 26220048
[TBL] [Abstract][Full Text] [Related]
2. The impact of renal tubular damage, as assessed by urinary β2-microglobulin-creatinine ratio, on cardiac prognosis in patients with chronic heart failure.
Otaki Y; Watanabe T; Shishido T; Takahashi H; Funayama A; Narumi T; Kadowaki S; Hasegawa H; Honda S; Netsu S; Ishino M; Arimoto T; Miyashita T; Miyamoto T; Konta T; Kubota I
Circ Heart Fail; 2013 Jul; 6(4):662-8. PubMed ID: 23674363
[TBL] [Abstract][Full Text] [Related]
3. Association of renal tubular damage with cardio-renal anemia syndrome in patients with heart failure.
Otaki Y; Watanabe T; Takahashi H; Narumi T; Kadowaki S; Honda Y; Arimoto T; Shishido T; Miyamoto T; Konta T; Kubota I
Int J Cardiol; 2014 May; 173(2):222-8. PubMed ID: 24630338
[TBL] [Abstract][Full Text] [Related]
4. Renal tubular damage and clinical outcome in heart failure with preserved ejection fraction and chronic kidney disease.
Otaki Y; Watanabe T; Shimizu M; Tachibana S; Sato J; Kobayashi Y; Saito Y; Aono T; Tamura H; Kato S; Nishiyama S; Takahashi H; Arimoto T; Watanabe M
ESC Heart Fail; 2023 Aug; 10(4):2458-2468. PubMed ID: 37264723
[TBL] [Abstract][Full Text] [Related]
5. Association of plasma thioredoxin-1 with renal tubular damage and cardiac prognosis in patients with chronic heart failure.
Otaki Y; Watanabe T; Takahashi H; Kadowaki S; Narumi T; Honda Y; Wanezaki M; Sasaki S; Tamura H; Nishiyama S; Arimoto T; Shishido T; Miyamoto T; Kubota I
J Cardiol; 2014 Nov; 64(5):353-9. PubMed ID: 24685687
[TBL] [Abstract][Full Text] [Related]
6. Renal tubular damage is associated with poor clinical outcome in patients with peripheral artery disease who underwent endovascular therapy.
Otaki Y; Watanabe T; Takahashi H; Yamaura G; Nishiyama S; Arimoto T; Shishido T; Miyamoto T; Kubota I
Int J Cardiol; 2016 Oct; 220():376-81. PubMed ID: 27390958
[TBL] [Abstract][Full Text] [Related]
7. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
[TBL] [Abstract][Full Text] [Related]
8. Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate.
Damman K; Van Veldhuisen DJ; Navis G; Vaidya VS; Smilde TD; Westenbrink BD; Bonventre JV; Voors AA; Hillege HL
Heart; 2010 Aug; 96(16):1297-302. PubMed ID: 20659949
[TBL] [Abstract][Full Text] [Related]
9. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy.
Mise K; Hoshino J; Ueno T; Hazue R; Hasegawa J; Sekine A; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
Clin J Am Soc Nephrol; 2016 Apr; 11(4):593-601. PubMed ID: 26801478
[TBL] [Abstract][Full Text] [Related]
11. Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio-SHiFT study).
Brankovic M; Akkerhuis KM; Hoorn EJ; van Boven N; van den Berge JC; Constantinescu A; Brugts J; van Ramshorst J; Germans T; Hillege H; Boersma E; Umans V; Kardys I
Clin Cardiol; 2020 Jun; 43(6):630-638. PubMed ID: 32298007
[TBL] [Abstract][Full Text] [Related]
12. Association of malnutrition with renal dysfunction and clinical outcome in patients with heart failure.
Otaki Y; Watanabe T; Shimizu M; Tachibana S; Sato J; Kobayashi Y; Saito Y; Aono T; Tamura H; Kato S; Nishiyama S; Takahashi H; Arimoto T; Watanabe M
Sci Rep; 2022 Oct; 12(1):16673. PubMed ID: 36198898
[TBL] [Abstract][Full Text] [Related]
13. Tubular damage and worsening renal function in chronic heart failure.
Damman K; Masson S; Hillege HL; Voors AA; van Veldhuisen DJ; Rossignol P; Proietti G; Barbuzzi S; Nicolosi GL; Tavazzi L; Maggioni AP; Latini R
JACC Heart Fail; 2013 Oct; 1(5):417-24. PubMed ID: 24621973
[TBL] [Abstract][Full Text] [Related]
14. Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure.
Damman K; van Veldhuisen DJ; Navis G; Voors AA; Hillege HL
Eur J Heart Fail; 2008 Oct; 10(10):997-1000. PubMed ID: 18804416
[TBL] [Abstract][Full Text] [Related]
15. Association of plasma xanthine oxidoreductase activity with severity and clinical outcome in patients with chronic heart failure.
Otaki Y; Watanabe T; Kinoshita D; Yokoyama M; Takahashi T; Toshima T; Sugai T; Murase T; Nakamura T; Nishiyama S; Takahashi H; Arimoto T; Shishido T; Miyamoto T; Kubota I
Int J Cardiol; 2017 Feb; 228():151-157. PubMed ID: 27865177
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for sodium valproate-induced renal tubular dysfunction.
Koga S; Kimata T; Yamanouchi S; Tsuji S; Yoshimura K; Araki A; Kaneko K
Clin Exp Nephrol; 2018 Apr; 22(2):420-425. PubMed ID: 28836089
[TBL] [Abstract][Full Text] [Related]
17. The renal arterial resistance index: a marker of renal function with an independent and incremental role in predicting heart failure progression.
Ciccone MM; Iacoviello M; Gesualdo L; Puzzovivo A; Antoncecchi V; Doronzo A; Monitillo F; Citarelli G; Paradies V; Favale S
Eur J Heart Fail; 2014 Feb; 16(2):210-6. PubMed ID: 24464953
[TBL] [Abstract][Full Text] [Related]
18. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
Hofstra JM; Deegens JK; Willems HL; Wetzels JF
Nephrol Dial Transplant; 2008 Aug; 23(8):2546-51. PubMed ID: 18308774
[TBL] [Abstract][Full Text] [Related]
19. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.
Niizeki T; Takeishi Y; Arimoto T; Takabatake N; Nozaki N; Hirono O; Watanabe T; Nitobe J; Harada M; Suzuki S; Koyama Y; Kitahara T; Sasaki T; Kubota I
J Card Fail; 2007 Mar; 13(2):120-7. PubMed ID: 17395052
[TBL] [Abstract][Full Text] [Related]
20. Cystatin C, a novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure.
Arimoto T; Takeishi Y; Niizeki T; Takabatake N; Okuyama H; Fukui A; Tachibana H; Nozaki N; Hirono O; Tsunoda Y; Miyashita T; Shishido T; Takahashi H; Koyama Y; Kubota I
J Card Fail; 2005 Oct; 11(8):595-601. PubMed ID: 16230262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
